To our surprise, IRF7 and IRF5 expression levels remained absent (Figure 3A, less than 1.5 fold increase for both IRF5 and IRF7) in lung cancer cell line CRL5810 after 5-aza-dC treatment for as long as 4 weeks. Here, IRF5 is linked to lung carcinoma.